132 related articles for article (PubMed ID: 25673149)
1. The miR-199a/Brm/EGR1 axis is a determinant of anchorage-independent growth in epithelial tumor cell lines.
Kobayashi K; Sakurai K; Hiramatsu H; Inada K; Shiogama K; Nakamura S; Suemasa F; Kobayashi K; Imoto S; Haraguchi T; Ito H; Ishizaka A; Tsutsumi Y; Iba H
Sci Rep; 2015 Feb; 5():8428. PubMed ID: 25673149
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers.
Sakurai K; Furukawa C; Haraguchi T; Inada K; Shiogama K; Tagawa T; Fujita S; Ueno Y; Ogata A; Ito M; Tsutsumi Y; Iba H
Cancer Res; 2011 Mar; 71(5):1680-9. PubMed ID: 21189327
[TBL] [Abstract][Full Text] [Related]
3. The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma.
Kinose Y; Sawada K; Nakamura K; Sawada I; Toda A; Nakatsuka E; Hashimoto K; Mabuchi S; Takahashi K; Kurachi H; Lengyel E; Kimura T
Oncotarget; 2015 May; 6(13):11342-56. PubMed ID: 25839163
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration.
Sarver AL; Li L; Subramanian S
Cancer Res; 2010 Dec; 70(23):9570-80. PubMed ID: 21118966
[TBL] [Abstract][Full Text] [Related]
5. MiR-199a inhibits the ability of proliferation and migration by regulating CD44-Ezrin signaling in cutaneous squamous cell carcinoma cells.
Wang SH; Zhou JD; He QY; Yin ZQ; Cao K; Luo CQ
Int J Clin Exp Pathol; 2014; 7(10):7131-41. PubMed ID: 25400809
[TBL] [Abstract][Full Text] [Related]
6. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2.
Shatseva T; Lee DY; Deng Z; Yang BB
J Cell Sci; 2011 Aug; 124(Pt 16):2826-36. PubMed ID: 21807947
[TBL] [Abstract][Full Text] [Related]
8. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L
Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828
[TBL] [Abstract][Full Text] [Related]
9. Early growth response gene 1, a TRBP binding protein, is involved in miRNA activity of miR-125a-3p in human cells.
Wei J; Ouyang Y; Li X; Zhu B; Yang J; Cui Y; Chen X; Lin F; Long M; Yang A; Dong K; Zhang H
Cell Signal; 2015 Jun; 27(6):1120-8. PubMed ID: 25725290
[TBL] [Abstract][Full Text] [Related]
10. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
[TBL] [Abstract][Full Text] [Related]
11. MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer.
Migliore C; Martin V; Leoni VP; Restivo A; Atzori L; Petrelli A; Isella C; Zorcolo L; Sarotto I; Casula G; Comoglio PM; Columbano A; Giordano S
Clin Cancer Res; 2012 Feb; 18(3):737-47. PubMed ID: 22179665
[TBL] [Abstract][Full Text] [Related]
12. MiR-199a-3p promotes gastric cancer progression by targeting ZHX1.
Wang Z; Ma X; Cai Q; Wang X; Yu B; Cai Q; liu B; Zhu Z; Li C
FEBS Lett; 2014 Nov; 588(23):4504-12. PubMed ID: 25448600
[TBL] [Abstract][Full Text] [Related]
13. miR-199a-5p inhibits monocyte/macrophage differentiation by targeting the activin A type 1B receptor gene and finally reducing C/EBPα expression.
Lin HS; Gong JN; Su R; Chen MT; Song L; Shen C; Wang F; Ma YN; Zhao HL; Yu J; Li WW; Huang LX; Xu XH; Zhang JW
J Leukoc Biol; 2014 Dec; 96(6):1023-35. PubMed ID: 25258381
[TBL] [Abstract][Full Text] [Related]
14. SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines.
Watanabe H; Mizutani T; Haraguchi T; Yamamichi N; Minoguchi S; Yamamichi-Nishina M; Mori N; Kameda T; Sugiyama T; Iba H
Oncogene; 2006 Jan; 25(3):470-9. PubMed ID: 16247481
[TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 promotes pituitary adenoma cells migration and invasion by regulating the interaction between EGR1 and KLF5.
Yang W; Xu T; Qiu P; Xu G
Exp Cell Res; 2018 Jun; 367(1):7-14. PubMed ID: 29309750
[TBL] [Abstract][Full Text] [Related]
16. [Identification of differently expressed microRNAs in keloid and pilot study on biological function of miR-199a-5p].
Wu ZY; Lu L; Guo XR; Zhang PH
Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Jul; 29(4):279-84. PubMed ID: 24228510
[TBL] [Abstract][Full Text] [Related]
17. The miR-199-dynamin regulatory axis controls receptor-mediated endocytosis.
Aranda JF; Canfrán-Duque A; Goedeke L; Suárez Y; Fernández-Hernando C
J Cell Sci; 2015 Sep; 128(17):3197-209. PubMed ID: 26163491
[TBL] [Abstract][Full Text] [Related]
18. The reversible epigenetic silencing of BRM: implications for clinical targeted therapy.
Glaros S; Cirrincione GM; Muchardt C; Kleer CG; Michael CW; Reisman D
Oncogene; 2007 Oct; 26(49):7058-66. PubMed ID: 17546055
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of RAC1-GEF DOCK3 by miR-512-3p contributes to suppression of metastasis in non-small cell lung cancer.
Zhu X; Gao G; Chu K; Yang X; Ren S; Li Y; Wu H; Huang Y; Zhou C
Int J Biochem Cell Biol; 2015 Apr; 61():103-14. PubMed ID: 25687035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
